Last update 08 May 2025

Proxodolol hydrochloride/Pilocarpine Hydrochloride

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Proksocarpin, Proksokarpin, Proxocarpin
+ [1]
Target
mAChRs x α-adrenergic receptor x β-adrenoceptors
Action
agonists, antagonists
Mechanism
mAChRs agonists(Muscarinic acetylcholine receptor agonists), α-adrenergic receptor antagonists(Alpha adrenergic receptor antagonists), β-adrenoceptors antagonists(Beta adrenergic receptors antagonists)
Therapeutic Areas
Eye Diseases
Active Indication
Glaucoma
Inactive Indication-
Originator Organization
Moscow Endocrine Plant
Active Organization
Moscow Endocrine Plant
Inactive Organization-
License Organization-
Drug Highest PhaseApproved
First Approval Date
Russia (01 May 2006),
Glaucoma
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC28H42ClN5O7
InChIKeyLRVWAIHIGUVUNO-ZCVIPUSMSA-N
CAS Registry392656-69-8

Related

100 Clinical Results associated with Proxodolol hydrochloride/Pilocarpine Hydrochloride
Login to view more data
100 Translational Medicine associated with Proxodolol hydrochloride/Pilocarpine Hydrochloride
Login to view more data
100 Patents (Medical) associated with Proxodolol hydrochloride/Pilocarpine Hydrochloride
Login to view more data
2
Literatures (Medical) associated with Proxodolol hydrochloride/Pilocarpine Hydrochloride
01 Feb 2013Pharmaceutical Chemistry Journal
Application of HPLC to the Analysis of Benzethonium Chloride in Eye Drops
01 Jan 2001Pharmaceutical Chemistry Journal
Preclinical experimental study of proxocarpine - a combined eyedrop form of proxodolol and pilocarpine
100 Deals associated with Proxodolol hydrochloride/Pilocarpine Hydrochloride
Login to view more data

External Link

KEGGWikiATCDrug Bank
--
S01EB51
-

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Glaucoma
Russia
Moscow Endocrine Plant
01 May 2006
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free